Charles S. Ryan's most recent trade in Quince Therapeutics Inc was a trade of 7,548 Warrants done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | Charles S. Ryan | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 7,548 | 7,548 | - | - | Warrants | |
| Quince Therapeutics Inc | Charles S. Ryan | President | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 18 Jun 2025 | 7,548 | 130,009 (0%) | 0% | 1.2 | 9,058 | Common Shares |
| Quince Therapeutics Inc | Charles S. Ryan | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | Charles S. Ryan | PRESIDENT | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 20 Aug 2024 | 48,387 | 122,461 (0%) | 0% | 0.7 | 31,452 | Common Stock |
| Quince Therapeutics Inc | Charles S. Ryan | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 145,000 | 145,000 | - | - | Employee Stock Option (right to buy) |